OBSN Share Price Performance
CHF 0
0.00 (0.00%)
Price CHF 0
Share Pricen/a
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
OBSN Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
ObsEva SA Key Details
Last Reported Earnings
Jun 30, 2023
Next Reporting Earnings
Sep 30, 2024
- 0.068
- 45.46%
- 40.34%
- 0%
About OBSN
- Founded
- 2012
- Employees
- 15
- CEO
- WebsiteView website
ObsEva SA, a biopharmaceutical company, focuses on the development of novel therapies to improve women’s reproductive health. It develops Nolasiban, an oral oxytocin receptor agonist for improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland.